$RXST Cashflow Statement | Understand Stock

$RXST

$4.93 -$0.09 (1.79%) Close

$RXST Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating Activities:
Net loss
Depreciation and amortization
Provision for bad debts
Amortization of right-of-use lease assets
Amortization of debt issuance costs and premium
Change in fair value of warrants
Gain on expiration of warrant
Loss on extinguishment of debt
Amortization of discount on short-term investments
Stock-based compensation
Gain on sale of equipment
Provision for excess and obsolete inventory
Change in operating assets and liabilities:
Accounts receivable
Inventories
Prepaid and other assets
Accounts payable
Accrued expenses and other liabilities
Net cash used in operating activities

Investing Activities:
Purchases of property and equipment
Proceeds from sale of equipment
Maturity of short-term investments
Purchase of short-term investments
Net cash (used in) provided by investing activities

Financing Activities:
Proceeds from term loan
Repayment of term loan
Proceeds from issuance of common stock from public offering
Proceeds from exercise of stock options and issuance of common stock under the employee stock purchase plan
Proceeds from issuance of common stock for at-the-market offerings
Proceeds from Issuance of Common Stock
Payments for employee taxes related to stock compensation
Principal payments on finance lease liabilities
Payments of deferred offering costs
Change in notes receivables for redeemable common stock issued
Proceeds from exercise of stock options
Payments of debt issuance costs
Proceeds from exercise of warrants
Net cash provided by financing activities

Effect of foreign exchange rate on cash, cash equivalents and restricted cash
Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash - beginning of period
Cash, cash equivalents and restricted cash - end of period
Supplemental disclosure of cash flow information:
Operating cash flows from operating leases
Cash paid for income taxes
Cash paid for interest on financing leases
Cash paid for interest on term loan
Non-cash investing and financing activities:
Right-of-use assets obtained in exchange for lease obligations:
Operating lease
Finance lease
Lease obligations recorded for right-of-use assets:
Operating lease
Finance lease
Acquisition of property and equipment included in accounts payable and accrued expenses and other current liabilities
Deferred offering costs included in accounts payable and accrued liabilities
Payment-in-kind interest income added to principal of notes receivable
Reclassification from warrant liability to additional paid-in capital for warrants exercised
Reclassification of 4,093,995 shares of redeemable common stock to 4,093,995 shares of common stock
Reclassification of redeemable common stock options to common stock options
Reclassification of deferred financing costs
Conversion of preferred stock to common stock upon initial public offering

Comments